Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes

CONCLUSION: SGLT2is increase overall survival and cancer-specific survival in patients with cancer in a dose-dependent manner.PMID:38036054 | DOI:10.1016/j.diabet.2023.101500

Source: Diabetes and Metabolism - November 30, 2023 Category: Endocrinology Authors: Yen-Min Huang Wan-Ming Chen An-Tzu Jao Mingchih Chen Ben-Chang Shia Szu-Yuan Wu Source Type: research